Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 235

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences

Volkow, Nora D., Li, Ting-Kai·2005·Pharmacology & Therapeutics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.pharmthera.2005.06.021

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Research works printed but not linked: 88

  1. Addolorato, 2000, Ability of baclofen in reducing alcohol craving and intake: II. Preliminary clinical evidence, Alcohol Clin Exp Res, 24, 67
  2. Amin, 2004, HIV and hepatitis C coinfection within the CAESAR study, HIV Med, 5, 174, 10.1111/j.1468-1293.2004.00207.x · DOI
  3. Balldin, 2003, A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence, Alcohol Clin Exp Res, 27, 1142, 10.1097/01.ALC.0000075548.83053.A9 · DOI · Paper page
  4. Benveniste, 2005, Maternal and fetal 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates, J Nucl Med, 46, 312
  5. Brebner, 2002, A potential role for GABA(B) agonists in the treatment of psychostimulant addiction, Alcohol Alcohol, 37, 478, 10.1093/alcalc/37.5.478 · DOI · Paper page
  6. Brebner, 2005, Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates, Psychopharmacology (Berl), 177, 409, 10.1007/s00213-004-1968-6 · DOI
  7. Breiter, 1997, Acute effects of cocaine on human brain activity and emotion, Neuron, 19, 591, 10.1016/S0896-6273(00)80374-8 · DOI · Paper page
  8. Brodie, 2003, Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA, Synapse, 50, 261, 10.1002/syn.10278 · DOI
  9. Campbell, 2002, Sex differences in the effects of baclofen on the acquisition of intravenous cocaine self-administration in rats, Drug Alcohol Depend, 66, 61, 10.1016/S0376-8716(01)00185-5 · DOI
  10. Carroll, 1998, Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram, Addiction, 93, 713, 10.1046/j.1360-0443.1998.9357137.x · DOI · Paper page
  11. Carroll, 2001, Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement, Arch Gen Psychiatry, 58, 755, 10.1001/archpsyc.58.8.755 · DOI · Paper page
  12. 2004, Diagnoses of HIV/AIDS-32 states, 2000–2003, MMWR Weekly, 53, 1106
  13. 2004, Alcohol consumption among women who are pregnant or who might become pregnant, MMWR Weekly, 53, 1178
  14. Chang, 2004, Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure, Psychiatry Res, 132, 95, 10.1016/j.pscychresns.2004.06.004 · DOI · Paper page
  15. Chefer, 2004, Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine, Neuroscience, 127, 497, 10.1016/j.neuroscience.2004.05.021 · DOI
  16. Chelonis, 2003, The effects of prenatal cocaine exposure on reversal learning using a simple visual discrimination task in rhesus monkeys, Neurotoxicol Teratol, 25, 437, 10.1016/S0892-0362(03)00017-5 · DOI
  17. Crits-Christoph, 1999, Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study, Arch Gen Psychiatry, 56, 493, 10.1001/archpsyc.56.6.493 · DOI · Paper page
  18. Dackis, 2003, Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study, Drug Alcohol Depend, 70, 29, 10.1016/S0376-8716(02)00335-6 · DOI · Paper page
  19. Day, 2004, An analysis of the effects of prenatal alcohol exposure on growth: a teratologic model, Am J Med Genet Part C Semin Med Genet, 127, 28, 10.1002/ajmg.c.30013 · DOI
  20. Elliot, 2004, Preventing substance use and disordered eating: initial outcomes of the ATHENA (athletes targeting healthy exercise and nutrition alternatives) program, Arch Pediatr Adolesc Med, 158, 1043, 10.1001/archpedi.158.11.1043 · DOI · Paper page
  21. Fiorentine, 2003, Why extensive participation in treatment and twelve-step programs is associated with the cessation of addictive behaviors: an application of the addicted-self model of recovery, J Addict Dis, 22, 35, 10.1300/J069v22n01_03 · DOI
  22. Fone, 2005, Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder, Curr Opin Pharmacol, 5, 87, 10.1016/j.coph.2004.10.001 · DOI
  23. Franklin, 2002, Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients, Biol Psychiatry, 51, 134, 10.1016/S0006-3223(01)01269-0 · DOI · Paper page
  24. Gerada, 2005, Drug misuse: a review of treatments, Clin Med, 5, 69, 10.7861/clinmedicine.5-1-69 · DOI
  25. Goldberg, 1996, Effects of a multidimensional anabolic steroid prevention intervention. The Adolescents Training and Learning to Avoid Steroids (ATLAS) Program, JAMA, 276, 1555, 10.1001/jama.276.19.1555 · doi:10.1001/jama.276.19.1555 · Paper page
  26. Goodwin, 2002, The relationship between anxiety and substance use disorders among individuals with severe affective disorders, Compr Psychiatry, 43, 245, 10.1053/comp.2002.33500 · DOI
  27. Grant, 2004, The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991–1992 and 2001–2002, Drug Alcohol Depend, 74, 223, 10.1016/j.drugalcdep.2004.02.004 · DOI · Paper page
  28. Grant, 2001, Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up, J Subst Abuse, 13, 493, 10.1016/S0899-3289(01)00096-7 · DOI · Paper page
  29. Hansen, 1993, Visual evoked potentials and visual processing in stimulant drug-exposed infants, Dev Med Child Neurol, 35, 798, 10.1111/j.1469-8749.1993.tb11731.x · doi:10.1111/j.1469-8749.1993.tb11731.x
  30. Hanson, 2004, The methamphetamine experience: a NIDA partnership, Neuropharmacology, 47, 92, 10.1016/j.neuropharm.2004.06.004 · DOI
  31. Higgins, 1993, Disulfiram therapy in patients abusing cocaine and alcohol, Am J Psychiatry, 150, 675, 10.1176/ajp.150.4.675b · DOI
  32. Higgins, 2002, Voucher-based incentives. A substance abuse treatment innovation, Addict Behav, 27, 887, 10.1016/S0306-4603(02)00297-6 · DOI · Paper page
  33. Hinds, 2005, Whole-genome patterns of common DNA variation in three human populations, Science, 307, 1072, 10.1126/science.1105436 · DOI · Paper page
  34. Hu, 2005, Repeated cocaine administration decreases calcineurin (PP2B) but enhances DARPP-32 modulation of sodium currents in rat nucleus accumbens neurons, Neuropsychopharmacology, 30, 916, 10.1038/sj.npp.1300654 · DOI
  35. Huestis, 2002, Drug abuse's smallest victims: in utero drug exposure, Forensic Sci Int, 128, 20, 10.1016/S0379-0738(02)00160-3 · DOI · Paper page
  36. Ibrahim, 2005, CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids, Proc Natl Acad Sci U S A, 102, 3093, 10.1073/pnas.0409888102 · DOI · Paper page
  37. Ikonomidou, 2000, Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome, Science, 287, 1056, 10.1126/science.287.5455.1056 · DOI · Paper page
  38. Kalivas, 2004, Glutamate systems in cocaine addiction, Curr Opin Pharmacol, 4, 23, 10.1016/j.coph.2003.11.002 · DOI · Paper page
  39. Kalivas, 2004, Recent understanding in the mechanisms of addiction, Curr Psychiatry Rep, 6, 347, 10.1007/s11920-004-0021-0 · DOI
  40. Kampman, 2004, A pilot trial of topiramate for the treatment of cocaine dependence, Drug Alcohol Depend, 75, 233, 10.1016/j.drugalcdep.2004.03.008 · DOI · Paper page
  41. Kendler, 2000, Childhood sexual abuse and adult psychiatric and substance use disorders in women: an epidemiological and cotwin control analysis, Arch Gen Psychiatry, 57, 953, 10.1001/archpsyc.57.10.953 · DOI · Paper page
  42. Klein, 1995, Sexual abuse during childhood and adolescence as predictors of HIV-related sexual risk during adulthood among female sexual partners of injection drug users, Violence Against Women, 1, 55, 10.1177/1077801295001001004 · DOI
  43. Koob, 1999, Stress, corticotropin-releasing factor, and drug addiction, Ann N Y Acad Sci, 897, 27, 10.1111/j.1749-6632.1999.tb07876.x · DOI · Paper page
  44. Kreek, 2004, Genes associated with addiction: alcoholism, opiate, and cocaine addiction, Neuromol Med, 5, 85, 10.1385/NMM:5:1:085 · DOI
  45. Lasser, 2000, Smoking and mental illness: a population-based prevalence study, JAMA, 284, 2606, 10.1001/jama.284.20.2606 · DOI · Paper page
  46. Le Foll, 2005, Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence, J Pharmacol Exp Ther, 312, 875, 10.1124/jpet.104.077974 · DOI · Paper page
  47. Lidow, 2003, Consequences of prenatal cocaine exposure in nonhuman primates, Brain Res Dev Brain Res, 147, 23, 10.1016/j.devbrainres.2003.09.001 · DOI
  48. Lineberry, 2004, Taking the physician out of “physician shopping”: a case series of clinical problems associated with Internet purchases of medication, Mayo Clin Proc, 79, 1031, 10.4065/79.8.1031 · DOI
  49. Litten, 2005, Development of medications for alcohol use disorders: Recent advances and ongoing challenges, Expert Opin Emerg Drugs, 10, 323, 10.1517/14728214.10.2.323 · DOI
  50. Lu, 2005, Central amygdala ERK signaling pathway is critical to incubation of cocaine craving, Nat Neurosci, 8, 212, 10.1038/nn1383 · DOI · Paper page
  51. McClung, 2004, DeltaFosB: a molecular switch for long-term adaptation in the brain, Brain Res Mol Brain Res, 132, 146, 10.1016/j.molbrainres.2004.05.014 · DOI · Paper page
  52. McCoy, 2004, Injection drug use and crack cocaine smoking: independent and dual risk behaviors for HIV infection, Ann Epidemiol, 14, 535, 10.1016/j.annepidem.2003.10.001 · DOI
  53. McFarland, 2003, Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior, J Neurosci, 23, 3531, 10.1523/JNEUROSCI.23-08-03531.2003 · DOI · Paper page
  54. McLellan, 2005, Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring, Addiction, 100, 447, 10.1111/j.1360-0443.2005.01012.x · DOI · Paper page
  55. Nath, 2002, Molecular basis for interactions of HIV and drugs of abuse, J Acquir Immune Defic Syndr, 31, S62, 10.1097/00126334-200210012-00006 · DOI · Paper page
  56. Nestler, 2004, Molecular mechanisms of drug addiction, Neuropharmacology, 47, 24, 10.1016/j.neuropharm.2004.06.031 · DOI · Paper page
  57. Nordstrom-Klee, 2002, Growth from birth onwards of children prenatally exposed to drugs: a literature review, Neurotoxicol Teratol, 24, 481, 10.1016/S0892-0362(02)00232-5 · DOI
  58. Olney, 2004, Fetal alcohol syndrome at the cellular level, Addict Biol, 9, 137, 10.1080/13556210410001717006 · DOI
  59. Oswald, 2004, Opioids and alcoholism, Physiol Behav, 81, 339, 10.1016/j.physbeh.2004.02.008 · DOI · Paper page
  60. Paltiel, 2005, Expanded screening for HIV in the United States—an analysis of cost-effectiveness, N Engl J Med, 352, 586, 10.1056/NEJMsa042088 · DOI · Paper page
  61. Petry, 2000, A comprehensive guide to the application of contingency management procedures in clinical settings, Drug Alcohol Depend, 58, 9, 10.1016/S0376-8716(99)00071-X · DOI · Paper page
  62. Rawson, 2002, Status of methamphetamine users 2–5 years after outpatient treatment, J Addict Dis, 21, 107, 10.1300/J069v21n01_09 · DOI
  63. Regier, 1990, Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study, JAMA, 264, 2511, 10.1001/jama.264.19.2511 · doi:10.1001/jama.264.19.2511 · Paper page
  64. Resnick, 1997, Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health, JAMA, 278, 823, 10.1001/jama.278.10.823 · DOI · Paper page
  65. Richardson, 1996, Prenatal cocaine exposure: effects on the development of school-age children, Neurotoxicol Teratol, 18, 627, 10.1016/S0892-0362(96)00121-3 · DOI · Paper page
  66. Safdar, 2004, Alcohol and hepatitis C, Semin Liver Dis, 24, 305, 10.1055/s-2004-832942 · DOI
  67. Sanders, 2005, Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy, N Engl J Med, 352, 570, 10.1056/NEJMsa042657 · DOI · Paper page
  68. Schiffer, 2003, Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine, Psychopharmacology (Berl), 168, 339, 10.1007/s00213-003-1446-6 · doi:10.1007/s00213-003-1446-6
  69. Schuster, 1992, Drug abuse research and HIV/AIDS: a national perspective from the US, Br J Addict, 87, 355, 10.1111/j.1360-0443.1992.tb01936.x · doi:10.1111/j.1360-0443.1992.tb01936.x
  70. Shively, 1997, Social stress, depression, and brain dopamine in female cynomolgus monkeys, Ann N Y Acad Sci, 807, 574, 10.1111/j.1749-6632.1997.tb51972.x · DOI
  71. Shoptaw, 2003, Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use, J Clin Psychiatry, 64, 1440, 10.4088/JCP.v64n1207 · DOI · Paper page
  72. Singer, 2004, Cognitive outcomes of preschool children with prenatal cocaine exposure, JAMA, 291, 2448, 10.1001/jama.291.20.2448 · DOI · Paper page
  73. Smith, 2001, Brain proton magnetic resonance spectroscopy in children exposed to methamphetamine in utero, Neurology, 57, 255, 10.1212/WNL.57.2.255 · DOI
  74. Sowell, 2002, Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure, Neuroimage, 17, 1807, 10.1006/nimg.2002.1328 · DOI
  75. Spear, 2000, The adolescent brain and age-related behavioral manifestations, Neurosci Biobehav Rev, 24, 417, 10.1016/S0149-7634(00)00014-2 · DOI · Paper page
  76. Stein, 1998, Nicotine-induced limbic cortical activation in the human brain: a functional MRI study, Am J Psychiatry, 155, 1009, 10.1176/ajp.155.8.1009 · DOI · Paper page
  77. Szumlinski, 2004, Homer proteins regulate sensitivity to cocaine, Neuron, 43, 401, 10.1016/j.neuron.2004.07.019 · DOI · Paper page
  78. Tapper, 2004, Nicotine activation of alpha4 receptors: sufficient for reward, tolerance, and sensitization, Science, 306, 1029, 10.1126/science.1099420 · DOI · Paper page
  79. Tarter, 1995, The association between childhood irritability and liability to substance use in early adolescence: a 2-year follow-up study of boys at risk for substance abuse, Drug Alcohol Depend, 39, 253, 10.1016/0376-8716(95)01175-6 · DOI
  80. Thompson, 2004, Structural abnormalities in the brains of human subjects who use methamphetamine, J Neurosci, 24, 6028, 10.1523/JNEUROSCI.0713-04.2004 · DOI · Paper page
  81. True, 1999, Common genetic vulnerability for nicotine and alcohol dependence in men, Arch Gen Psychiatry, 56, 655, 10.1001/archpsyc.56.7.655 · DOI · Paper page
  82. Van Gaal, 2005, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, 365, 1389, 10.1016/S0140-6736(05)66374-X · DOI · Paper page
  83. Volkow, 2004, The reality of comorbidity: depression and drug abuse, Biol Psychiatry, 56, 714, 10.1016/j.biopsych.2004.07.007 · DOI · Paper page
  84. Yu, 2003, Heart disease, methamphetamine and AIDS, Life Sci, 73, 129, 10.1016/S0024-3205(03)00260-1 · DOI
  85. Yuferov, 2003, Differential gene expression in the rat caudate putamen after “binge” cocaine administration: advantage of triplicate microarray analysis, Synapse, 48, 157, 10.1002/syn.10198 · DOI · Paper page
  86. Zhang, 2002, The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression, J Neurochem, 82, 1453, 10.1046/j.1471-4159.2002.01089.x · DOI
  87. Zhang, 2005, Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors, Neuropsychopharmacology, 10.1038/sj.npp.1300680 · DOI
  88. Zhu, 2000, Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway, J Immunol, 165, 373, 10.4049/jimmunol.165.1.373 · DOI · Paper page

Cited by

See all 235

Metadata

Authors
Volkow, N. D., & Li, T.-K.
Venue
Pharmacology & Therapeutics
Publisher
Elsevier BV
Published
2005-10
Volume
108
Issue
1
Pages
3-17
ISSN
0163-7258 (ISSN-L)
OpenAlex
W2044367989
Cited by
235
References
21
FWCI
7.20
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences. https://app.cochat.ai/papers/10.1016/j.pharmthera.2005.06.021
The paper
Volkow, N. D., & Li, T.-K. (2005). Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2005.06.021

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.